Welcome to medications.com

Gemfibrozil Information

What's inside Gemfibrozil

Gemfibrozil Active Ingredients: gemfibrozil, details.
Gemfibrozil Dosages & Strengths
Strength Format Route Strength Class
Gemfibrozil 600 mg tablet oral 1.0 each OTC
Gemfibrozil - powder compounding 100.0 gram(s) OTC

Recent Gemfibrozil Side Effects

Posted by marymargolen41 over 2 years ago
I feel light headed and my feet were swollen and i feel shaky

Posted by blenee over 2 years ago
I lose my balance. And this did not happen before I started taking gemfibrozil.

Posted by majdich over 3 years ago
Cramping large muscle in front of legs.


Gemfibrozil in the News

Drugs in Water Hurt Fish and Wildlife - The Associated Press
... hormones found in the Chicago River; abnormalities in Japanese zebra fish; ibuprofen, gemfibrozil, triclosan and naproxen in the lower Great Lakes. ...
Mon Mar 10 13:11:20 -0400 2008

BIP: New analyses suggest significant effect of bezafibrate - TheHeart.Org
... the difference in the rate of death/MI between bezafibrate and placebo (around 15% to 18%) is similar to that seen in the VA-HIT trial with gemfibrozil. ...
Wed Jan 23 16:04:31 -0500 2008

Tests home in on new hope against bird flu - The Australian
Led by Ian Clark of the Australian National University (ANU), the researchers used gemfibrozil, a drug already approved for human use as a ...
Fri Jan 18 09:09:17 -0500 2008


Gemfibrozil Chemical Information

gemfibrozil - A fibric acid derivative with hypolipidemic effects. Gemfibrozil interacts with peroxisome proliferator-activated receptors (PPARalpha) resulting in PPARalpha-mediated stimulation of fatty acid oxidation and an increase in lipoprotein lipase (LPL) synthesis. This enhances triglyceride-rich lipoprotein clearance and reduces the expression of apolipoprotein C-III (apoC-III). The reduction in hepatic production of apoC-III results in subsequent reduction of serum levels of very-low-density-lipoprotein cholesterol (VLDL-C). In addition, gemfibrozil-mediated PPARalpha stimulation of apoA-I and apoA-II expression results in an increase in high-density lipoprotein cholesterol (HDL-C).



Related Drugs
Related drugs contain similar ingredients


ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com